Chest X-Ray (CXR) — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

A chest X-ray (CXR) is a plain radiograph of the thorax produced by passing a controlled, low-dose beam of ionising X-ray radiation through the chest, which is captured on a digital detector or film plate positioned behind the patient. Different tissues absorb X-rays at different rates: dense structures such as bone and calcified lesions appear white (radiopaque), air-filled lung appears black (radiolucent), and soft tissues such as the heart and mediastinal vessels appear in intermediate shades of grey. The standard posteroanterior (PA) projection — taken with the X-ray beam passing from the back (posterior) to the front (anterior) — is the primary view, with the patient standing upright and taking a full inspiratory breath. This produces an accurately sized image of the heart (cardiac silhouette) and optimally expanded lungs. A lateral view, taken from the side, adds depth and allows localisation of lesions behind the heart or in specific lung lobes. The anteroposterior (AP) portable view, obtained at the bedside in acutely unwell patients, magnifies the cardiac silhouette and provides less diagnostic detail than the PA view. CXR is interpreted by radiologists and reporting clinicians and remains the most widely performed radiological investigation globally, forming the cornerstone of thoracic assessment.

CXR is ordered across an enormous range of clinical presentations and surveillance requirements. Common acute indications include new or worsening breathlessness, productive cough with fever (suspected pneumonia), haemoptysis (coughing blood), pleuritic chest pain (to exclude pneumothorax or pleural effusion), chest trauma (rib fractures, pneumothorax, haemothorax, aortic injury), and acute breathlessness in known cardiac disease. Chronic or monitoring indications include assessment of heart failure severity and treatment response (serial cardiac silhouette and pulmonary oedema changes), monitoring of pulmonary tuberculosis, sarcoidosis, pulmonary fibrosis, and malignant mesothelioma. Pre-operative assessment includes a CXR for patients over fifty years, those with cardiorespiratory disease, or before major surgery to provide a baseline. Cancer staging and follow-up uses CXR to detect pulmonary metastases and monitor known lung cancer. Occupational medicine uses CXR for screening of workers exposed to asbestos, silica, and other pneumoconiosis-causing dust. Emergency applications include rapid exclusion of tension pneumothorax, foreign body inhalation, and cardiomediastinal widening in chest trauma. Pregnant women should receive a CXR when clinically indicated — the radiation dose is negligible with abdominal shielding.

The patient is asked to remove jewellery, metal fastenings, and clothing from the chest to avoid artefact on the image. In the radiography department, the patient stands approximately one hundred and eighty centimetres from the X-ray tube, facing the digital imaging plate or cassette. Arms are placed away from the chest walls and shoulders are rotated forwards to move the shoulder blades laterally, exposing the posterior lung fields. A deep breath is taken and held — lung expansion optimises visualisation of the lung parenchyma and moves the hemidiaphragms downwards for better lower lobe assessment. The radiographer activates the X-ray beam remotely from behind a protective screen for approximately a fraction of a second. A lateral film is taken with the patient turned ninety degrees and the arms raised, with the side of interest closest to the detector. For bedside AP films in ward or ICU patients, a portable X-ray machine is used with the detector behind the patient's back, though image quality and positioning are less optimal. Total time including patient positioning is five to ten minutes. Images appear within seconds on digital systems (PACS) and are immediately accessible to radiologists for reporting. The effective radiation dose is approximately 0.01–0.02 millisieverts — equivalent to two to three days of natural background radiation.

The chest X-ray provides rapid, low-cost, broadly available imaging of the thorax with acceptable diagnostic accuracy for the majority of common conditions presenting to emergency and general medicine. For pneumonia, CXR demonstrates lobar or segmental consolidation in eighty-five to ninety percent of cases, though early or atypical infections and immunocompromised patients may have normal initial films. Cardiomegaly (cardiothoracic ratio greater than 0.5) is identified reliably on a technically adequate PA film. Pulmonary oedema features — upper lobe venous diversion, Kerley B lines, perihilar haziness, and pleural effusions — are identifiable in moderate-to-severe heart failure with over eighty percent sensitivity. Pneumothorax is visible on a PA inspiration film in eighty-five to ninety percent of significant cases; small or apical pneumothoraces may require an expiratory or lateral film. Large pleural effusions appear as homogeneous opacification of the lower hemithorax. Lung cancer presents as a soft tissue mass or nodule, though lesions smaller than ten millimetres and those obscured by the heart, hila, or diaphragm may be missed — CT chest detects significantly more lesions. Serial CXR in intensive care monitors line, tube, and drain positions and allows rapid assessment of changes in critically ill patients. The ACR Appropriateness Criteria guide the appropriate use of CXR versus CT for specific clinical scenarios.

The radiation dose from a single PA CXR is 0.01–0.02 millisieverts — exceptionally low and equivalent to approximately two to three days of natural background radiation exposure received from cosmic rays, radon in soil, and background radioactivity. At this dose, the risk of radiation-induced malignancy is negligibly small (estimated excess lifetime cancer risk of approximately one in one million for a single CXR). Repeated CXRs contribute cumulatively but remain far below doses associated with measurable increased risk. In pregnant women, the foetal radiation dose from a CXR with abdominal shielding is approximately 0.001 millisieverts — orders of magnitude below the ten millisieverts threshold of measurable foetal risk. CXR should not be withheld from pregnant women when clinically indicated. Limitations of CXR must be recognised: it is a two-dimensional representation of three-dimensional anatomy; lesions obscured by the heart, mediastinum, or diaphragm may be missed; early interstitial disease and small pleural effusions (below two hundred millilitres) may not be detected; and lymph node enlargement at the hila requires CT for confirmation. Any CXR finding of concern should be assessed in the clinical context and, where uncertainty remains, escalated to CT chest for definitive characterisation.

No recovery period is required after a chest X-ray. Patients can eat, drink, drive, and resume all activities immediately after the examination. There are no restrictions on activity, diet, or medication. The examination itself takes five to ten minutes, and results are digitally available to the requesting clinician within minutes to hours in most hospitals. Formal radiologist reporting is provided within a few hours during working hours or the next day for non-urgent requests. Urgent or critical findings — including tension pneumothorax, large pleural effusion, foreign body, severe pulmonary oedema, and widened mediastinum — are communicated directly and immediately to the requesting team by the radiologist. Patients attending radiology as outpatients are typically advised to contact their doctor or practice nurse for results rather than waiting in the department, unless a radiologist has been asked to discuss findings directly. Follow-up imaging — either repeat CXR at a scheduled interval to monitor treatment response, or escalation to CT chest for further characterisation — is arranged by the requesting clinician based on the radiological findings and clinical context.